TTRX TURN THERAPEUTICS INC revenue, earnings and financials
For the quarter ended June 30, 2026, TURN THERAPEUTICS INC reported revenue of n/a, net income of −$5.85M and diluted EPS of −$0.20; for the fiscal year ended December 2025 revenue was n/a.
TTRX annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$5.86M, net income −$3.19M (margin n/a), EPS −$0.12
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$1.80M, net income −$1.77M (margin n/a), EPS −$0.07
TTRX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$5.85M, EPS −$0.20
- Quarter ended Mar 31, 2026: revenue n/a, net income −$971K, EPS −$0.03
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income $279K, EPS $0.01
- Quarter ended Sep 30, 2025: revenue n/a, net income −$1.90M, EPS −$0.07
- Quarter ended Jun 30, 2025: revenue n/a, net income −$1.24M, EPS −$0.05
- Quarter ended Mar 31, 2025: revenue n/a, net income −$329K, EPS −$0.01
- Quarter ended Sep 30, 2024: revenue n/a, net income −$666K, EPS −$0.03
TTRX cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$2.56M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$1.36M, share buybacks n/a
TTRX balance sheet
- Jun 30, 2026: cash $9.95M, total assets $17.0M, total liabilities $16.3M, shareholders' equity $687K, long-term debt $6.06M
- Mar 31, 2026: cash $11.0M, total assets $18.6M, total liabilities $12.5M, shareholders' equity $6.12M, long-term debt $5.94M
- Dec 31, 2025: cash $4.03M, total assets $12.2M, total liabilities $7.48M, shareholders' equity $4.69M
- Sep 30, 2025: cash $514K, total assets $4.30M, total liabilities $3.79M, shareholders' equity $504K
- Dec 31, 2024: cash $498K, total assets $2.05M, total liabilities $2.23M, shareholders' equity −$177K
Is TTRX profitable?
No. TURN THERAPEUTICS INC lost $8.45M over the last four quarters.
What is TTRX's EPS?
Diluted earnings per share over the last four quarters were −$0.29; −$0.20 in the latest quarter.